Prevalence of and risk factors for fungal vaginitis caused by non-albicans species

被引:73
作者
Spinillo, A
Capuzzo, E
Gulminetti, R
Marone, P
Colonna, L
Piazzi, G
机构
[1] ISTITUTO RICOVERO & CURA CARRATTERE SCI POLICLIN,DEPT OBSTET & GYNECOL,PAVIA,ITALY
[2] ISTITUTO RICOVERO & CURA CARRATTERE SCI POLICLIN,DEPT INFECT DIS,PAVIA,ITALY
关键词
mycotic vaginitis; non-albicans species; fungal infections;
D O I
10.1016/S0002-9378(97)80026-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to evaluate the prevalence of symptomatic yeast vaginitis caused by non-albicans species among patients attending a vaginitis clinic over an 8-year period. STUDY DESIGN: A retrospective study of 1263 patients with symptomatic yeast vaginitis confirmed by culture techniques was performed. RESULTS: The prevalence of symptomatic fungal vaginitis caused by non-albicans species increased from 9.9% (10/101) in 1988 to 17.2% (36/209) in 1995 (chi(2) for trend = 9.33, p = 0.002). Non-albicans species were found more frequently in known human immunodeficiency virus-seropositive patients (23/102 vs 143/1161, odds ratio 2.07, 95% confidence interval 1.2 to 3.46) than in seronegative subjects or subjects of unknown status for the virus. Recurrent vaginal candidiasis was an additional risk factor for vaginitis caused by non-albicans species (odds ratio 2.47, 95% confidence interval 1.72 to 3.52). The increase in non-albicans isolates during the study period was confirmed in stratified analysis and in the subgroup of self-referred patients with no history of either human immunodeficiency virus infection or recurrent vaginal candidiasis. CONCLUSION: The prevalence of fungal vaginitis caused by non-albicans species has increased sharply in the setting of a vaginitis clinic. The characteristics of risk factors suggest that fungal cultures should be done routinely in human immunodeficiency virus-seropositive subjects with suspected vaginal candidiasis and in patients with recurrent vaginal infection.
引用
收藏
页码:138 / 141
页数:4
相关论文
共 12 条
[1]  
BINGHAM JS, 1986, ACTA DERM-VENER S, V121, P39
[2]   CAN WE PREVENT AZOLE RESISTANCE IN FUNGI [J].
DENNING, DW .
LANCET, 1995, 346 (8973) :454-455
[3]   MYCOTIC VULVO-VAGINITIS - A BROAD OVERVIEW [J].
HOROWITZ, BJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (04) :1188-1192
[4]   EMERGENCE OF AZOLE DRUG-RESISTANCE IN CANDIDA SPECIES FROM HIV-INFECTED PATIENTS RECEIVING PROLONGED FLUCONAZOLE THERAPY FOR ORAL CANDIDOSIS [J].
JOHNSON, EM ;
WARNOCK, DW ;
LUKER, J ;
PORTER, SR ;
SCULLY, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (01) :103-114
[5]   HIGH PREVALENCE OF ANTIFUNGAL RESISTANCE IN CANDIDA SPP FROM PATIENTS WITH AIDS [J].
LAW, D ;
MOORE, CB ;
WARDLE, HM ;
GANGULI, LA ;
KEANEY, MGL ;
DENNING, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (05) :659-668
[6]   CHRONIC FUNGAL VAGINITIS - THE VALUE OF CULTURES [J].
NYIRJESY, P ;
SEENEY, SM ;
GRODY, MHT ;
JORDAN, CA ;
BUCKLEY, HR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (03) :820-823
[7]  
Odds F.C., 1988, CANDIDA CANDIDOSIS R
[8]  
REDONDOLOPEZ V, 1990, OBSTET GYNECOL, V76, P651
[9]   VAGINAL INFECTIONS IN ADULT WOMEN [J].
SOBEL, JD .
MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (06) :1573-1602
[10]   CANDIDAL VULVO-VAGINITIS [J].
SOBEL, JD .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1993, 36 (01) :153-165